A rapid and sensitive liquid chromatography-mass spectrometric (LC-MS/MS) quantification method has been developed and validated for the determination of genotoxic impurity in lansoprazole (LNZ) dosage form. Initially, the method was developed for the separation of genotoxic impurity of LNZ by HPLC. After successful separation of the impurities on HPLC, the method was transferred to LC-MS/MS to achieve the required sensitivity. The chromatographic separation was achieved on a Hypersil BDS C-18 (150 X 4.6 mm, 5µm) column using mobile phase containing buffer (0.01M Ammonium acetate), Acetonitrile and methanol in 50:45:5 v/v ratio. Methanol was used as diluent. The flow rate was 0.8mL min-1 and elution was monitored at 205 nm. The mass of 2-Chloromethyl-3-methyl-4-(2,2,2-trifluoroethoxy) pyridine Hydrochloride was m/z 240(M+H + ) with electrospray ionization with positive mode with ion spray voltage is 4500 volts. Lansoprazole and 2-Chloromethyl-3-methyl-4-(2,2,2trifluoroethoxy) pyridine Hydrochloride elution order was observed from total ion chromatogram in scan mode. Validation was done in selective ion monitoring (SIM) mode. The calibration curves obtained were linear (R 2 -0.9984) over the concentration range of 0.90-2.40 µg/mL. The overall average recovery was found to be 97.6-98.2%. The developed method was validated with respect to specificity, LOD, LOQ, linearity, accuracy, precision as per ICH guidelines.
INTRODUCTION
Lansoprazole, chemically describes 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2pyridinyl]methyl]sulfinyl]-1H-enzimidazole, is an important proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of the gastric (H + , K + ) ATPase enzyme system. Lansoprazole is effective in the treatment of various peptic diseases, including gastric and duodenal ulcer and reflux esophagitis, Zollinger-Ellison syndrome and functional dyspepsia. [1] [2] [3] [4] [5] In the synthesis of Lansoprazole (1), 2-Chloromethyl-3-methyl-4-(2,2,2trifluoroethoxy) pyridine Hydrochloride (2) is key and important intermediate. The definition of genotoxicity is broad and includes both direct and indirect effects on DNA. 6 Genotoxic impurities could cause somatic mutations, carcinogenic or cause cancer on humans. [7] [8] As per the regulatory guidelines, a threshold of toxicological concern (TTC) value of 1.5µg day -1 in the taking of genotoxic impurities are permitted in the drug product. Based on the literature of the survey, there were several analytical methods for the determination of genotoxic impurities in lansoprazole limit of detection was 0.9 ppm. These include; High-performance liquid chromatography (HPLC), Electrochemical and spectrophotometric methods. [9] [10] [11] [12] [13] GENOTOXIC IMPURITIES IN LANSOPRAZOLE V. Venkateswarlu et al.
The literature reports a few spectrophotometric methods for the quantitation of genotoxic impurities. Some of the reported HPLC methods need sophisticated instruments or do not describe analytical parameters that are very important for the validation of analytical procedure such as accuracy, specificity, linearity, the limit of detection (LOD limit of quantitation (LOQ). It is important to develop and validate analytical methods for its determination of genotoxic impurities.
The objective of the present study to develop highly sensitive, selective and accurate method development on LC-MS/MS technique to get good resolution between Lansoprazole and genotoxic impurity. The developed method was validated in terms of specificity, the limit of detection (LOD), the limit of quantitation (LOD), precision, linearity, and accuracy as per ICH guidelines. 14 
EXPERIMENTAL Chemicals and Materials
Lansoprazole and 2-Chloromethyl-3-methyl-4-(2,2,2-trifluoroethoxy) pyridine Hydrochloride impurity were received from the process research department of Matrix laboratories ltd., Hyderabad, India. Ammonium acetate, Triethylamine, Acetonitrile, and methanol were purchased from Merck Chemicals (Mumbai, India).
Equipment
An Agilent 1200 LC system coupled with an API 3000 system (Applied Biosystems, Canada) with analyst software, version 1.6.2. LC. volumetric flask and diluted to volume with diluent. Further diluted 0.9 mL of this solution to 100 mL with diluent.
Preparation of Standard Solution

Preparation of Sample Solution
Weighed about 100 mg of sample into a 10 mL volumetric flask, and diluted volume with diluents and made up to volume with diluent and mixed well. Specificity 2-chloro methyl-3-methyl-4-(2,2,2-trifluoro.ethoxy)pyridine hydrochloride impurity and Lansoprazole was freshly prepared at a concentration of 0.1mg/ml in diluent. In this method 2-chloro methyl-3-methyl-4-(2,2,2-trifluoro ethoxy) pyridine hydrochloride impurity was monitored by its molecular ion m/z 240 (Protonated), which is specific fragment ion for 2-chloro methyl-3-methyl-4-(2,2,2-trifluoro ethoxy) pyridine hydrochloride. Lansoprazole was monitored by its molecular ion 370 (Protonated). Table 1 summarizes the retention time (RT) values and mass number (m/z) values obtained 2-chloro methyl-3methyl-4-(2,2,2-trifluoro ethoxy) pyridine hydrochloride and a representative selective ion chromatogram was presented in Fig.-4 . 
LC-MS/MS Conditions
Limit of Detection (LOD) and Limit of Quantitation (LOQ)
To establish the limit of detection (LOD) and limit of quantitation (LOQ) of 2-chloro methyl-3-methyl-4-(2,2,2-trifluoro ethoxy) pyridine hydrochloride impurity was prepared 5 ppm solution with respect to sample concentration (Lansoprazole) was injected. Based on the signal to noise ratio of impurity a series of solutions prepared to achieve the signal to noise ratios (S/N) of 3:1 and 10:1 respectively. The results are summarized in Table-2 
Precision at LOQ
The precision at LOQ of 2-chloro methyl-3-methyl-4-(2,2,2-trifluoro ethoxy) pyridine hydrochloride impurity was evaluated by injecting LOQ solution six times into system. The %RSD of impurity peak areas were found to be 1.9.
Linearity
To demonstrate the linearity of detector response for 2-chloro methyl-3-methyl-4-(2, 2, 2-trifluoro ethoxy) pyridine hydrochloride impurity, injected the solutions with concentrations ranging from LOQ level to 2.40ppm. Plot a graph of concentrations on X-axis versus peak areas on Y-axis and determined the slope, Intercept, Multiple R, R square from linearity graph. The corresponding results and linearity graph were summarized in Table-3 
Accuracy
The accuracy at the limit of Quantitation was determined by analyzing a solution containing Lansoprazole.spiked.with.2-chloro.methyl-3-methyl-4-(2,2,2-trifluoro.ethoxy)pyridine hydrochloride impurity at LOQ level of the working strength of API. The percentage recovery obtained for the 2-chloro methyl-3-methyl-4-(2,2,2-trifluoro ethoxy) pyridine hydrochloride impurity. The results are summarized in Table-4 . 
Sample Analysis
In order to verify the sensitivity and specificity of this method in a real-time situation, the present method was used to quantitate the Genotoxic impurity of lansoprazole using the lansoprazole 30mg tablet and the impurity was quantitated at 0.3 ppm.
